Suggested Topics within your search.
Suggested Topics within your search.
Augmented renal clearance
1
Bevacizumab
1
Biological Products
1
Biosimilar
1
Biotransformation
1
Covalent bonds
1
Critically ill patient
1
Disulphide bond shuffling
1
Disulphide bonds
1
Dosing
1
Drug Industry
1
Drug products
1
Humans
1
IgG1 therapeutics
1
Igg1 therapeutic
1
LC-MS-MS
1
LC-MS/MS
1
Lc.ms/ms
1
Levetiracetam
1
Monte Carlo simulation
1
Neurocritical care
1
Pharmacodynamics
1
Pharmacokinetics
1
Post-translational modifications
1
Protein degradation
1
Protein therapeutics
1
Proteins
1
Sulfur compounds
1
biological product
1
biosimilars
1
-
241by Bieleszová, Dominika“...Efficiency and bioavaibility of antimycotic drugs are limited due to many biopharmaceutical...”
Published 2019
Get full text
Dissertation -
242“... biopharmaceutics classification system (BCS)-II drug, aceclofenac. Although a number of attempts to increase...”
Get full text
Article -
243
-
244by Antonino Natalello, Diletta Ami, Maddalena Collini, Laura D'Alfonso, Giuseppe Chirico, Giancarlo Tonon, Silvia Scaramuzza, Rodolfo Schrepfer, Silvia Maria Doglia“... biopharmaceuticals. To overcome this problem several strategies can be exploited, as the conjugation of the protein...”
Published 2012-01-01
Get full text
Article -
245“... are associated with poor physicochemical and biopharmaceutical properties, which makes the formulation difficult...”
Get full text
Article -
246“... the biopharmaceutical challenges of zerumbone. The purpose of this review is to provide a comprehensive perspective...”
Get full text
Article -
247“... and biopharmaceutical significance. However, much still remains to be answered in terms of SLC22 family member's roles...”
Get full text
Article -
248“...Celecoxib (CLX), a selective COX-2 inhibitor, is a biopharmaceutics classification system (BCS...”
Get full text
Article -
249by Chiranjib Chakraborty, Ashish Ranjan Sharma, Garima Sharma, C. George Priya Doss, Sang-Soo Lee“... of the most important biopharmaceuticals that are in commercial space as future medicines. This review...”
Published 2017-09-01
Get full text
Article -
250by Gi-Ho Son, Young-Guk Na, Hyun Wook Huh, Miao Wang, Min-Ki Kim, Min-Gu Han, Jin-Ju Byeon, Hong-Ki Lee, Cheong-Weon Cho“...Ticagrelor (TGL), a P2Y<sub>12</sub> receptor antagonist, is classified as biopharmaceutics...”
Published 2019-05-01
Get full text
Article -
251by Rob N de Jong, Frank J Beurskens, Sandra Verploegen, Kristin Strumane, Muriel D van Kampen, Marleen Voorhorst, Wendy Horstman, Patrick J Engelberts, Simone C Oostindie, Guanbo Wang, Albert J R Heck, Janine Schuurman, Paul W H I Parren“...) patient tumor cells, while retaining regular pharmacokinetics and biopharmaceutical developability. Both...”
Published 2016-01-01
Get full text
Article -
252by Aung Naing, Jeffrey Infante, Sanjay Goel, Howard Burris, Chelsea Black, Shannon Marshall, Ikbel Achour, Susannah Barbee, Rena May, Chris Morehouse, Kristen Pollizzi, Xuyang Song, Keith Steele, Nairouz Elgeioushi, Farzana Walcott, Joyson Karakunnel, Patricia LoRusso, Amy Weise, Joseph Eder, Brendan Curti, Michael Oberst“...Abstract Background The safety, efficacy, pharmacokinetics, and pharmacodynamics of the anti...”
Published 2019-08-01
Get full text
Article -
253
-
254Design of Prodrugs to Enhance Colonic Absorption by Increasing Lipophilicity and Blocking Ionizationby Rebecca Nofsinger, Sophie-Dorothee Clas, Rosa I. Sanchez, Abbas Walji, Kimberly Manser, Becky Nissley, Jaume Balsells, Amrithraj Nair, Qun Dang, David Jonathan Bennett, Michael Hafey, Junying Wang, John Higgins, Allen Templeton, Paul Coleman, Jay Grobler, Ronald Smith, Yunhui Wu“... their pharmacokinetic, pharmacodynamic and/or biopharmaceutical properties. Ideally, prodrugs are efficiently converted...”
Published 2014-02-01
Get full text
Article -
255“... on pharmacokinetics and pharmacodynamics. Modulation of glycan profile is frequently needed in biosimilar development...”
Get full text
Article -
256“...Hao-Wen Kao,1 Yi-Yu Lin,1 Walter J Gwathney,1 Keelung Hong1,2 1TLC Biopharmaceuticals, Inc., South...”
Get full text
Article -
257by Nkiruka Ibeanu, Raphael Egbu, Lesley Onyekuru, Hoda Javaheri, Peng Tee Khaw, Gareth R. Williams, Steve Brocchini, Sahar Awwad“... of biopharmaceutical production and formulation. Polypeptides often display poor pharmacokinetics, limited permeability...”
Published 2020-10-01
Get full text
Article -
258by Cristina Helena dos Reis Serra, Kyung Hee Chang, Thaisa Marinho Dezani, Valentina Porta, Sílvia Storpirtis“...>in vitro</italic>biopharmaceutical features. The oral bioequivalence study was performed in twenty-four...”
Published 2015-06-01
Get full text
Article -
259“.... In this study, we examined its uptake, biodistribution and pharmacokinetics after peroral administration in both...”
Get full text
Article -
260by Chang, Michelle, Gaidukov, Leonid, Jung, Giyoung, Tseng, Wen Allen, Scarcelli, John J., Cornell, Richard, Marshall, Jeffrey K., Lyles, Jonathan L, Sakorafas, Paul, Chu, An-Hsiang Adam, Cote, Kaffa, Tzvetkova, Boriana, Dolatshahi, Sepideh, Sumit, Madhuresh, Mulukutla, Bhanu Chandra, Lauffenburger, Douglas A, Figueroa, Bruno, Summers, Nevin M, Lu, Timothy K, Weiss, RonGet fulltext
Published 2020
Article